NCT02133625View on ClinicalTrials.gov

A Study of Pioglitazone and Carboplatin in Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Advanced Solid TumorMetastatic Solid Tumor
Interventions
DRUG

carboplatin

DRUG

pioglitazone

Trial Locations (2)

02115

Dana-Farber Cancer Institute, Boston

02215

Brigham and Women's Hospital, Boston

All Listed Sponsors
lead

Dana-Farber Cancer Institute

OTHER

NCT02133625 - A Study of Pioglitazone and Carboplatin in Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter